# Larimar Therapeutics, Inc.: Form SC 13D/A, filed Jul 2, 2021

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: SC 13D/A
- Filed: 2021-07-02
- Accepted by EDGAR: Jul 2, 2021, 17:08 ET
- Period: not reported
- Accession: 0001193805-21-000975
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119380521000975/e620771_sc13da-lt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119380521000975/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119380521000975/e620771_sc13da-lt.htm

Filed Jul 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001193805-21-000975. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
